Publications
Partners
Image supplied
If you have high blood sugar or hyperglycaemia, there is the danger that you might develop Type 2 diabetes mellitus, one of the most significant of the group of chronic lifestyle diseases making up the Metabolic Syndrome. However, if remedied and returned to normal levels, someone with high blood sugar can avoid the onset of Type 2 diabetes.
There are two main types of diabetes:
Type 1 diabetes which is an autoimmune disease and the diabetes that most often occurs in childhood, although adults can also develop this type of diabetes.
Type 2 diabetes used to be called mature onset diabetes, but is now called Type 2 diabetes because it now increasingly occurs in children, adolescents and younger adults. Type 2 diabetes accounts for between 85% and 95% of all diabetes in the developed world, with even higher percentages in some developing countries. More women than men have Type 2 diabetes.
Prevalence of diabetes
Preventing Chronic Diseases: a vital investment, a 2005 World Health Organization (WHO) report states that more than 60% of all deaths worldwide were attributable to chronic diseases, with 80% of these occurring in low and middle income countries.
Cardiovascular disease, with 17 million deaths in 2005, is by far the largest contributor to global disease-related mortality. Diabetes is a major risk factor for cardiovascular disease, which accounts for between 50% and 80% of diabetes-related deaths. The cost of the diabetes pandemic in humanistic terms is enormous.
Diabetes prevalence fast facts
• Diabetes is the seventh leading cause of death in the USA
• In the USA it is also the leading cause of lower-limb amputation, end-stage renal disease and blindness in people aged between 18 and 65.
• Current data reveals that Type 2 diabetes is more prevalent in the developed than the developing world, but that the developing world will bear most of the brunt of the burgeoning pandemic.
• In developed countries, the age group over 65 reflects the highest prevalence for the disease.
• In the developing world greater prevalence occurs in the age group 45 to 64.
To put the rapid growth in diabetes prevalence into some perspective: In 2000, Diabetes was estimated to directly affect 171 million people worldwide and to account for at least 3.2 million deaths, or six deaths every minute.
In 2007 the International Diabetes Federation (IDF) predicted that by 2025 some 380 million people would have diabetes, with approximately 70% living in low and middle income countries. In 2013, just six years later, the IDF revised their estimate and stated that their data reveals that 382 million people already have diabetes.
Why is diabetes so prevalent?
The question then is, how did we go from 30 million people with diabetes in 1985, to 171 million in 2000 and then to 383 million in 2013? Read more about this serious but preventable chronic disease in Part 2 of the discussion on Hyperglycaemia and Diabetes.
If you have high blood sugar and you feel you may be at risk for Type 2 diabetes, one of the chronic lifestyle diseases associated with Metabolic Syndrome, visit a Dis-Chem pharmacy, get tested and get help.
Met-S Care works with Dis-Chem Pharmacies to empower people living with Metabolic Syndrome to take control of their condition.
There are two main types of diabetes:
Type 1 diabetes which is an autoimmune disease and the diabetes that most often occurs in childhood, although adults can also develop this type of diabetes.
Type 2 diabetes used to be called mature onset diabetes, but is now called Type 2 diabetes because it now increasingly occurs in children, adolescents and younger adults. Type 2 diabetes accounts for between 85% and 95% of all diabetes in the developed world, with even higher percentages in some developing countries. More women than men have Type 2 diabetes.
Prevalence of diabetes
Preventing Chronic Diseases: a vital investment, a 2005 World Health Organization (WHO) report states that more than 60% of all deaths worldwide were attributable to chronic diseases, with 80% of these occurring in low and middle income countries.
Cardiovascular disease, with 17 million deaths in 2005, is by far the largest contributor to global disease-related mortality. Diabetes is a major risk factor for cardiovascular disease, which accounts for between 50% and 80% of diabetes-related deaths. The cost of the diabetes pandemic in humanistic terms is enormous.
Diabetes prevalence fast facts
• Diabetes is the seventh leading cause of death in the USA
• In the USA it is also the leading cause of lower-limb amputation, end-stage renal disease and blindness in people aged between 18 and 65.
• Current data reveals that Type 2 diabetes is more prevalent in the developed than the developing world, but that the developing world will bear most of the brunt of the burgeoning pandemic.
• In developed countries, the age group over 65 reflects the highest prevalence for the disease.
• In the developing world greater prevalence occurs in the age group 45 to 64.
To put the rapid growth in diabetes prevalence into some perspective: In 2000, Diabetes was estimated to directly affect 171 million people worldwide and to account for at least 3.2 million deaths, or six deaths every minute.
In 2007 the International Diabetes Federation (IDF) predicted that by 2025 some 380 million people would have diabetes, with approximately 70% living in low and middle income countries. In 2013, just six years later, the IDF revised their estimate and stated that their data reveals that 382 million people already have diabetes.
Why is diabetes so prevalent?
The question then is, how did we go from 30 million people with diabetes in 1985, to 171 million in 2000 and then to 383 million in 2013? Read more about this serious but preventable chronic disease in Part 2 of the discussion on Hyperglycaemia and Diabetes.
If you have high blood sugar and you feel you may be at risk for Type 2 diabetes, one of the chronic lifestyle diseases associated with Metabolic Syndrome, visit a Dis-Chem pharmacy, get tested and get help.
Met-S Care works with Dis-Chem Pharmacies to empower people living with Metabolic Syndrome to take control of their condition.
